Shoulder Innovations

19.7502.12% ( +0.410 )

Closed: Oct 22, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -11.74, below the reasonable range, cheaper than 91.57% of the time in the past 1 years, and the industry ranks 135/172, the industry Median -0.92.

-11.74xP/E

Stock price$19.75Earnings per share$-1.68

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

014284256

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-12.48x	140.96%	$13.26B
GKOSUSGlaukos	-55.42x	75.37%	$10.42B
TFXUSTeleflex	-5.61x	118.39%	$5.79B
IRTCUSIRhythm	-282.76x	71.47%	$3.94B
PLSEUSPulse Biosciences	-46.93x	26.85%	$3.76B
ASSTUSStrive	-3.69x	63.23%	$3.60B
AXGNUSAxogen	-64.15x	16.18%	$2.15B
BFLYUSButterfly Network	-24.23x	31.45%	$1.81B
NVCRUSNovocure	-11.84x	1.23%	$1.76B
ATECUSAlphatec	-15.95x	41.67%	$1.75B
KMTSUSKestra Medical Tech	-11.07x	0.79%	$1.66B
ENOVUSEnovis	-1.13x	100.97%	$1.25B
TNDMUSTandem Diabetes	-18.85x	77.60%	$1.19B
DRTSUSAlpha Tau Medical	-12.87x	--	$1.19B
AORTUSArtivion	-366.24x	266.67%	$1.17B
PRCTUSPROCEPT BioRobotics	-10.45x	3.47%	$1.15B
CBLLUSCeribell	-15.93x	35.15%	$1.05B
BBNXUSBeta Bionics	-13.95x	11.45%	$1.02B
SIBNUSSI-BONE	-66.04x	8.85%	$966.29M
QDELUSQuidelOrtho	-0.88x	75.33%	$924.40M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.